ClinicalTrials.Veeva

Menu

Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status (VKA and RHD)

A

Ahmed Hassan Rostom Ibrahim

Status

Not yet enrolling

Conditions

Rheumatic Heart Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07146282
VKA in RHD current status

Details and patient eligibility

About

VKA in RHD patients with MHV: our current status

Full description

Vitamin K Antagonist in Rheumatic heart disease patients with mechanical heart valves: Our Current Status

Enrollment

165 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed presence of a mechanical heart valve.
  • Aged ≥18 years

Exclusion criteria

  • Pregnancy.
  • Active bleeding disorders.
  • Severe liver/kidney disease (if affecting anticoagulation).

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed Hassan Rostom, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems